Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-14

FDA Approved: RIVAROXABAN — Original Application (Dr.Reddy's Laboratories, Inc.)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' generic rivaroxaban for marketing (ANDA 208534), expanding access to the direct oral anticoagulant. The generic is intend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

ORIG AP for RIVAROXABAN (RIVAROXABAN)